We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+1.69%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$22.4B
AUM Growth
+$745M
Cap. Flow
+$687M
Cap. Flow %
3.07%
Top 10 Hldgs %
31.51%
Holding
1,352
New
72
Increased
666
Reduced
342
Closed
71

Top Buys

Rank Stock Value
1
AMT icon
American Tower
AMT
+$191M
2
MSFT icon
Microsoft
MSFT
+$116M
3
NVDA icon
NVIDIA
NVDA
+$115M
4
AAPL icon
Apple
AAPL
+$108M
5
WY icon
Weyerhaeuser
WY
+$83.8M

Sector Composition

Rank Sector Weight
1 Real Estate 37.54%
2 Technology 23.33%
3 Communication Services 8.01%
4 Consumer Discretionary 6.37%
5 Financials 5.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMMT icon
1051
Summit Therapeutics
SMMT
$9.9B
$43K ﹤0.01%
2,434
-225
-8% -$4.36K
INSM icon
1052
Insmed
INSM
$22.7B
$41K ﹤0.01%
590
-45
-7% -$3.24K
STRA icon
1053
Strategic Education
STRA
$1.88B
$41K ﹤0.01%
440
-40
-8% -$3.73K
MDV
1054
Modiv Industrial
MDV
$183M
$40K ﹤0.01%
2,656
LWLG icon
1055
Lightwave Logic
LWLG
$840M
$36K ﹤0.01%
17,182
+5,414
+46% +$15.5K
NNDM
1056
Nano Dimension
NNDM
$316M
$35K ﹤0.01%
13,988
-9,965
-42% -$23K
MEDP icon
1057
Medpace
MEDP
$15.9B
$34K ﹤0.01%
103
-14
-12% -$4.75K
HTHT icon
1058
Huazhu Hotels Group
HTHT
$13.3B
$33K ﹤0.01%
+1,000
New +$36.2K
EXEL icon
1059
Exelixis
EXEL
$14B
$31K ﹤0.01%
942
-110
-10% -$3.57K
BLDP
1060
Ballard Power Systems
BLDP
$790M
$30K ﹤0.01%
18,265
-4,834
-21% -$7.53K
ITCI
1061
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$29K ﹤0.01%
350
-50
-13% -$4.11K
LLYVA icon
1062
Liberty Live Group Series A
LLYVA
$9.08B
$27K ﹤0.01%
+420
New +$26.1K
ONC
1063
BeOne Medicines Ltd
ONC
$33.8B
$27K ﹤0.01%
146
-12
-8% -$2.45K
JAZZ icon
1064
Jazz Pharmaceuticals
JAZZ
$16B
$25K ﹤0.01%
200
-37
-16% -$4.36K
UDMY
1065
DELISTED
Udemy
UDMY
$25K ﹤0.01%
2,980
EWZ icon
1066
iShares MSCI Brazil ETF
EWZ
$9B
$22K ﹤0.01%
980
MDGL icon
1067
Madrigal Pharmaceuticals
MDGL
$12.5B
$22K ﹤0.01%
72
-11
-13% -$3.09K
HALO icon
1068
Halozyme
HALO
$9.85B
$20K ﹤0.01%
420
-49
-10% -$2.51K
IONS icon
1069
Ionis Pharmaceuticals
IONS
$9.13B
$19K ﹤0.01%
541
BPMC
1070
DELISTED
Blueprint Medicines
BPMC
$18K ﹤0.01%
210
-27
-11% -$2.47K
COUR icon
1071
Coursera
COUR
$1.72B
$18K ﹤0.01%
2,080
-500
-19% -$3.86K
CYTK icon
1072
Cytokinetics
CYTK
$10.8B
$18K ﹤0.01%
389
-45
-10% -$2.34K
BBIO icon
1073
BridgeBio Pharma
BBIO
$16.5B
$17K ﹤0.01%
624
-31,085
-98% -$803K
NUVL
1074
DELISTED
Nuvalent
NUVL
$17K ﹤0.01%
217
CRNX icon
1075
Crinetics Pharmaceuticals
CRNX
$8.88B
$16K ﹤0.01%
304

Similar funds

Daiwa Securities Group's Q4 2024 Portfolio in Review

As of Q4 2024, Daiwa Securities Group held 1,352 positions worth $22.4B, up 3.4% from $21.6B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Daiwa Securities Group deployed $687M of net new capital in Q4 2024, opening 72 new positions and adding to 666 existing holdings. Its largest new stake was Curbline Properties: 2,033,334 shares worth $47.2M.

By sector, the portfolio is most concentrated in Real Estate at 38% of assets, down from 42% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $118M trimmed.

  • Daiwa Securities Group's largest Q4 2024 buy was Curbline Properties: 2,033,334 shares worth $47.2M.
  • Daiwa Securities Group added most to American Tower in Q4 2024, an estimated $191M increase.
  • Daiwa Securities Group's biggest Q4 2024 reduction was iShares Core S&P 500 ETF, cutting an estimated $118M.
  • Daiwa Securities Group fully exited State Street SPDR S&P 500 ETF Trust in Q4 2024, selling an estimated $10.3M.
  • Daiwa Securities Group's ten largest holdings make up 32% of its $22.4B portfolio in Q4 2024.
  • Daiwa Securities Group opened 72 new positions and closed 71 in Q4 2024.
  • Daiwa Securities Group's portfolio value rose 3.4% quarter-over-quarter to $22.4B.

Based on Daiwa Securities Group's 13F filing for Q4 2024, filed 7 Feb 2025.